As CGM Options Expand, Innovators See an Edge
The continuous glucose monitoring market is dominated by Abbott, Dexcom, and Medtronic, but this $10+ billion worldwide opportunity has attracted several others, including two innovative start-ups—Biolinq and Allez Health—that closed on substantial investment rounds this year and one longstanding competitor, Senseonics, that recently launched the first year-long CGM implantable.
Read Article